Listeria monocytogenesInfection Overcomes the Requirement for CD40 Ligand in Exogenous Antigen Presentation to CD8+ T Cells
Open Access
- 15 November 2001
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 167 (10) , 5603-5609
- https://doi.org/10.4049/jimmunol.167.10.5603
Abstract
In vivo priming of CD8+ T lymphocytes against exogenously processed model Ags requires CD4+ T cell help, specifically interactions between CD40 ligand (CD40L) expressed by activated CD4+ T cells and CD40, which is present on professional APC such as dendritic cells (DCs). To address this issue in the context of bacterial infection, we examined CD40L-CD40 interactions in CD8+ T cell priming against an exogenously processed, nonsecreted bacterial Ag. CD40L interactions were blocked by in vivo treatment with anti-CD40L mAb MR-1, which inhibited germinal center formation and CD8+ T cell cross-priming against an exogenous model Ag, OVA. In contrast, MR-1 treatment did not interfere with CD8+ T cell priming against a nonsecreted or secreted recombinant Ag expressed by Listeria monocytogenes. Memory and secondary responses of CD8+ T cells against nonsecreted and secreted bacterial Ags were also largely unimpaired by transient MR-1 treatment. When MR-1-treated mice were concurrently immunized with L. monocytogenes and OVA-loaded splenocytes, cross-priming of OVA-specific naive CD8+ T cells occurred. No significant decline in cross-priming against OVA was measured when either TNF or IFN-γ was neutralized in L. monocytogenes-infected animals, demonstrating that multiple signals exist to overcome CD40L blockade of CD8+ T cell cross-priming during bacterial infection. These data support a model in which DCs can be stimulated in vivo through signals other than CD40, becoming APC that can effectively stimulate CD8+ T cell responses against exogenous Ags during infection.Keywords
This publication has 42 references indexed in Scilit:
- Cd8+ but Not Cd8− Dendritic Cells Cross-Prime Cytotoxic T Cells in VivoThe Journal of Experimental Medicine, 2000
- CD8+T-Cell Priming against a NonsecretedListeria monocytogenesAntigen Is Independent of the Antimicrobial Activities of Gamma InterferonInfection and Immunity, 2000
- The CD40–CD154 system in anti-infective host defenseCurrent Opinion in Immunology, 1997
- CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response.The Journal of Experimental Medicine, 1996
- Specific immunity to listeria monocytogenes in the absence of IFNγImmunity, 1995
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994
- Strategies of Anti‐Cytokine Monoclonal Antibody Development: Immunoassay of IL‐10 and IL‐5 in Clinical SamplesImmunological Reviews, 1992
- Introduction of soluble protein into the class I pathway of antigen processing and presentationCell, 1988
- Role of hemolysin for the intracellular growth of Listeria monocytogenes.The Journal of Experimental Medicine, 1988
- Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies.The Journal of Experimental Medicine, 1987